ECSY88 personal page - To The Moon

ECSY88

ECSY88

No personal profile

44Follow

1Followers

0Topic

0Badge

01-24

BABA.... soaring soon.

01-24

Great ariticle, would you like to share it?

@Optionspuppy:Earnings for 4th quarter is on a positive note look at the futures

2022-12-23

[Smile]

Sorry, the original content has been removed

2022-09-02

[Smile]

3 Dividend Stocks to Buy in September for Passive Income Generation

2022-08-25

No...

Is Tesla's Stock Split Good For Investors?

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":4094208649095680,"uuid":"4094208649095680","gmtCreate":1631105584435,"gmtModify":1669036177588,"name":"ECSY88","pinyin":"ecsy88","introduction":"","introductionEn":"","signature":"","avatar":"https://community-static.tradeup.com/news/2ca1c7b2466a90f08306b9efc33770f1","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":44,"tweetSize":5,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.06.05","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.11.25","exceedPercentage":"60.55%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.01.30","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.29","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":266507427373096,"gmtCreate":1706100814428,"gmtModify":1706100819245,"author":{"id":"4094208649095680","authorId":"4094208649095680","name":"ECSY88","avatar":"https://community-static.tradeup.com/news/2ca1c7b2466a90f08306b9efc33770f1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"BABA.... soaring soon.","listText":"BABA.... soaring soon.","text":"BABA.... soaring soon.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/266507427373096","isVote":1,"tweetType":1,"viewCount":282,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":266507225415960,"gmtCreate":1706100778427,"gmtModify":1706102391617,"author":{"id":"4094208649095680","authorId":"4094208649095680","name":"ECSY88","avatar":"https://community-static.tradeup.com/news/2ca1c7b2466a90f08306b9efc33770f1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/266507225415960","repostId":"265790492557464","repostType":1,"repost":{"id":265790492557464,"gmtCreate":1705910690889,"gmtModify":1705925769143,"author":{"id":"4089501973615070","authorId":"4089501973615070","name":"Optionspuppy","avatar":"https://static.tigerbbs.com/caf34258aff8afe478620b82647f1199","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"title":"Earnings for 4th quarter is on a positive note look at the futures ","htmlText":"** Fortune-Telling: Earnings Edition 🔮💸** **Point 1: The Trumpian Gaze into the Future** 👀🔮 I've got a tremendous talent, folks – looking at futures earnings, and let me tell you, they're positive for many, many days before the market opens. It's like predicting my next great business move – you just gotta have that instinct. **Point 2: Strong Earnings, Trump-Style** 📈💪 So, based on my tremendous foresight, I'm predicting strong earnings for most of the Nasdaq and S&amp;P stocks. It's like a winning streak at one of my luxurious golf courses – you can't lose. **Point 3: The Big Guns: Google, Amazon, Apple, Microsoft** 🚀💰 Now, let's talk about the big players – Google, Amazon, Apple, and Microsoft. These guys are sitting on a mountain of cash, and let me tell you, that's a big, beautiful","listText":"** Fortune-Telling: Earnings Edition 🔮💸** **Point 1: The Trumpian Gaze into the Future** 👀🔮 I've got a tremendous talent, folks – looking at futures earnings, and let me tell you, they're positive for many, many days before the market opens. It's like predicting my next great business move – you just gotta have that instinct. **Point 2: Strong Earnings, Trump-Style** 📈💪 So, based on my tremendous foresight, I'm predicting strong earnings for most of the Nasdaq and S&amp;P stocks. It's like a winning streak at one of my luxurious golf courses – you can't lose. **Point 3: The Big Guns: Google, Amazon, Apple, Microsoft** 🚀💰 Now, let's talk about the big players – Google, Amazon, Apple, and Microsoft. These guys are sitting on a mountain of cash, and let me tell you, that's a big, beautiful","text":"** Fortune-Telling: Earnings Edition 🔮💸** **Point 1: The Trumpian Gaze into the Future** 👀🔮 I've got a tremendous talent, folks – looking at futures earnings, and let me tell you, they're positive for many, many days before the market opens. It's like predicting my next great business move – you just gotta have that instinct. **Point 2: Strong Earnings, Trump-Style** 📈💪 So, based on my tremendous foresight, I'm predicting strong earnings for most of the Nasdaq and S&P stocks. It's like a winning streak at one of my luxurious golf courses – you can't lose. **Point 3: The Big Guns: Google, Amazon, Apple, Microsoft** 🚀💰 Now, let's talk about the big players – Google, Amazon, Apple, and Microsoft. These guys are sitting on a mountain of cash, and let me tell you, that's a big, beautiful","images":[{"img":"https://community-static.tradeup.com/news/a370ee8ccfcb2eb9aa93329dffac13df","width":"1242","height":"1145"},{"img":"https://community-static.tradeup.com/news/425fb214f5056404c676b9876dc8cee8","width":"1536","height":"2048"},{"img":"https://community-static.tradeup.com/news/3105b1b305cb79675afd1e2a09599626","width":"1242","height":"2004"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/265790492557464","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":4,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":340,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9922540339,"gmtCreate":1671808379222,"gmtModify":1676538597162,"author":{"id":"4094208649095680","authorId":"4094208649095680","name":"ECSY88","avatar":"https://community-static.tradeup.com/news/2ca1c7b2466a90f08306b9efc33770f1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"[Smile]&nbsp;","listText":"[Smile]&nbsp;","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9922540339","repostId":"9922552955","repostType":1,"isVote":1,"tweetType":1,"viewCount":368,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9939226018,"gmtCreate":1662120753735,"gmtModify":1676537002269,"author":{"id":"4094208649095680","authorId":"4094208649095680","name":"ECSY88","avatar":"https://community-static.tradeup.com/news/2ca1c7b2466a90f08306b9efc33770f1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"[Smile]&nbsp;","listText":"[Smile]&nbsp;","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9939226018","repostId":"2264296558","repostType":4,"repost":{"id":"2264296558","pubTimestamp":1662107204,"share":"https://www.laohu8.com/m/news/2264296558?lang=&edition=full","pubTime":"2022-09-02 16:26","market":"us","language":"en","title":"3 Dividend Stocks to Buy in September for Passive Income Generation","url":"https://stock-news.laohu8.com/highlight/detail?id=2264296558","media":"Motley Fool","summary":"Buying these stocks now could lead to dividend payments that grow for the rest of your life.","content":"<html><head></head><body><p>Do you like getting paid to do practically nothing? I thought so.</p><p>Lots of savvy investors know that they can generate heaps of passive income with dividend-paying stocks. These three businesses are more than just reliable dividend payers; they&#39;re known for raising their dividend payouts year after year. Here&#39;s how they could provide ever-increasing dividend payments to your brokerage account.</p><h2>1. <a href=\"https://laohu8.com/S/ABT\">Abbott Laboratories </a></h2><p>This healthcare conglomerate&#39;s COVID-19 tests made it a stock market darling in 2021. Shares of <a href=\"https://laohu8.com/S/ABT\">Abbott Laboratories </a> have tumbled around 27% since the beginning of 2022 in response to subsiding demand for COVID tests. Now the stock offers a tempting 1.8% dividend yield that could rise significantly in the years ahead.</p><p>In the second quarter, COVID-19 testing-related sales fell to $2.3 billion from $3.3 billion during the first quarter of 2022. Luckily for long-term investors, the company could report significant earnings growth even if COVID-19 sales fall off a cliff.</p><p>Declining COVID-19 testing revenue isn&#39;t a major issue for this diversified conglomerate because its diabetes-care segment is about to rocket higher. In May, the FDA granted clearance to Abbott&#39;s FreeStyle Libre 3 system. This device is only the size of a couple of pennies stacked together, but once a patient sticks it on her or his arm, it monitors blood sugar levels constantly for two weeks.</p><p>Constant monitoring leads to fewer interventions in expensive hospitals, so insurers and government payers are eager to reimburse patients for the devices. With glucose monitoring sales about to explode higher, Abbott could approve some big dividend raises in the foreseeable future.</p><h2>2. <a href=\"https://laohu8.com/S/CVS\">CVS Health </a></h2><p>Shares of <a href=\"https://laohu8.com/S/CVS\">CVS Health </a> surged late last year when the company announced that it would begin raising its dividend payout again. Since then, the stock has been in a holding pattern.</p><p>At recent prices, shares of CVS Health offer a 2.2% yield that could grow significantly in the years ahead. In addition to thousands of retail pharmacies, this conglomerate owns a pharmacy benefits management business that boasts more than 110 million plan members.</p><p>Integrating a pharmacy benefits management business is one advantage its peers in the retail pharmacy space can&#39;t match, and it isn&#39;t the company&#39;s only big advantage. CVS Health previously paused raising its dividend payout to pay off its acquisition of Aetna, a health insurer that currently collects premiums from an estimated 35 million members.</p><p>CVS Health&#39;s unique combination of related businesses allowed the company to raise its dividend payout by 10% this year. Without any competitors combining a large retail footprint with a health benefits management business, the latest big payout bump could be the first of many in the years ahead.</p><h2>3. <a href=\"https://laohu8.com/S/ABBV\">AbbVie </a></h2><p><a href=\"https://laohu8.com/S/ABBV\">AbbVie </a> was once the pharmaceutical segment of Abbott Laboratories. Shares of AbbVie offer an above-average yield of 4.2% that could climb even higher.</p><p>Since the drugmaker spun off in 2013, its dividend has risen an astonishing 253% on the back of its lead drug, Humira. Second-quarter sales of Humira rose 9.6% year over year to a stunning $4.7 billion in the U.S. Unfortunately, international Humira revenue fell 13.8% to $699 million.</p><p>AbbVie offers an above-average dividend now because U.S. Humira sales will soon go the same way as international sales. An interchangeable biosimilar version of the anti-inflammatory blockbuster became available in the U.S. this July.</p><p>AbbVie investors can expect their dividend payouts to continue rising in the face of Humira competition because the company has new blockbuster drugs to pick up the slack. Second-quarter sales of Rinvoq, a new arthritis drug, and Skyrizi, a new psoriasis drug, soared 75% year over year to a combined $1.84 billion. With new blockbusters to offset Humira losses, AbbVie shareholders could see more big payout bumps in the years ahead.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Dividend Stocks to Buy in September for Passive Income Generation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Dividend Stocks to Buy in September for Passive Income Generation\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-09-02 16:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/09/01/3-dividend-stocks-to-buy-in-september-for-passive/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Do you like getting paid to do practically nothing? I thought so.Lots of savvy investors know that they can generate heaps of passive income with dividend-paying stocks. These three businesses are ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/09/01/3-dividend-stocks-to-buy-in-september-for-passive/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4581":"高盛持仓","CVS":"西维斯健康","BK4139":"生物科技","ABT":"雅培","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4568":"美国抗疫概念","BK4504":"桥水持仓","BK4566":"资本集团","BK4535":"淡马锡持仓","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓","ABBV":"艾伯维公司"},"source_url":"https://www.fool.com/investing/2022/09/01/3-dividend-stocks-to-buy-in-september-for-passive/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2264296558","content_text":"Do you like getting paid to do practically nothing? I thought so.Lots of savvy investors know that they can generate heaps of passive income with dividend-paying stocks. These three businesses are more than just reliable dividend payers; they're known for raising their dividend payouts year after year. Here's how they could provide ever-increasing dividend payments to your brokerage account.1. Abbott Laboratories This healthcare conglomerate's COVID-19 tests made it a stock market darling in 2021. Shares of Abbott Laboratories  have tumbled around 27% since the beginning of 2022 in response to subsiding demand for COVID tests. Now the stock offers a tempting 1.8% dividend yield that could rise significantly in the years ahead.In the second quarter, COVID-19 testing-related sales fell to $2.3 billion from $3.3 billion during the first quarter of 2022. Luckily for long-term investors, the company could report significant earnings growth even if COVID-19 sales fall off a cliff.Declining COVID-19 testing revenue isn't a major issue for this diversified conglomerate because its diabetes-care segment is about to rocket higher. In May, the FDA granted clearance to Abbott's FreeStyle Libre 3 system. This device is only the size of a couple of pennies stacked together, but once a patient sticks it on her or his arm, it monitors blood sugar levels constantly for two weeks.Constant monitoring leads to fewer interventions in expensive hospitals, so insurers and government payers are eager to reimburse patients for the devices. With glucose monitoring sales about to explode higher, Abbott could approve some big dividend raises in the foreseeable future.2. CVS Health Shares of CVS Health  surged late last year when the company announced that it would begin raising its dividend payout again. Since then, the stock has been in a holding pattern.At recent prices, shares of CVS Health offer a 2.2% yield that could grow significantly in the years ahead. In addition to thousands of retail pharmacies, this conglomerate owns a pharmacy benefits management business that boasts more than 110 million plan members.Integrating a pharmacy benefits management business is one advantage its peers in the retail pharmacy space can't match, and it isn't the company's only big advantage. CVS Health previously paused raising its dividend payout to pay off its acquisition of Aetna, a health insurer that currently collects premiums from an estimated 35 million members.CVS Health's unique combination of related businesses allowed the company to raise its dividend payout by 10% this year. Without any competitors combining a large retail footprint with a health benefits management business, the latest big payout bump could be the first of many in the years ahead.3. AbbVie AbbVie  was once the pharmaceutical segment of Abbott Laboratories. Shares of AbbVie offer an above-average yield of 4.2% that could climb even higher.Since the drugmaker spun off in 2013, its dividend has risen an astonishing 253% on the back of its lead drug, Humira. Second-quarter sales of Humira rose 9.6% year over year to a stunning $4.7 billion in the U.S. Unfortunately, international Humira revenue fell 13.8% to $699 million.AbbVie offers an above-average dividend now because U.S. Humira sales will soon go the same way as international sales. An interchangeable biosimilar version of the anti-inflammatory blockbuster became available in the U.S. this July.AbbVie investors can expect their dividend payouts to continue rising in the face of Humira competition because the company has new blockbuster drugs to pick up the slack. Second-quarter sales of Rinvoq, a new arthritis drug, and Skyrizi, a new psoriasis drug, soared 75% year over year to a combined $1.84 billion. With new blockbusters to offset Humira losses, AbbVie shareholders could see more big payout bumps in the years ahead.","news_type":1},"isVote":1,"tweetType":1,"viewCount":189,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9995181170,"gmtCreate":1661429341893,"gmtModify":1676536516656,"author":{"id":"4094208649095680","authorId":"4094208649095680","name":"ECSY88","avatar":"https://community-static.tradeup.com/news/2ca1c7b2466a90f08306b9efc33770f1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"No...","listText":"No...","text":"No...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9995181170","repostId":"2262018006","repostType":4,"repost":{"id":"2262018006","pubTimestamp":1661419523,"share":"https://www.laohu8.com/m/news/2262018006?lang=&edition=full","pubTime":"2022-08-25 17:25","market":"us","language":"en","title":"Is Tesla's Stock Split Good For Investors?","url":"https://stock-news.laohu8.com/highlight/detail?id=2262018006","media":"Seeking Alpha","summary":"This will be the second time that Tesla splits its stock. Tesla previously did a 5-for-1 stock split on Aug. 31, 2020. Shares have risen over 100% since then.Is Tesla's Stock Split Good For Investors?This is probably the most important question for most investors and also the most difficult to answer.There'ssome evidencethat companies that split their stock outperform in aggregate in the short term, perhaps in part because splitting allows some stocks to be included in indexes like the Dow and i","content":"<html><head></head><body><p><b>Summary</b></p><ul><li>I answer some of the most common questions from investors about stock splits.</li><li>Stock splits don&#39;t matter nearly as much as fundamentals, but they&#39;re certainly not bad for investors.</li><li>I also recap Tesla&#39;s recent Q2 earnings report.</li></ul><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ea05668b1422a0e51297e199e4d62ddc\" tg-width=\"1080\" tg-height=\"720\" referrerpolicy=\"no-referrer\"/><span>Ajax9/iStock Editorial via Getty Images</span></p><p><b>Thesis</b></p><p>After Q2 earnings, I updated my price target for Tesla (NASDAQ:TSLA) stock to $765 pre-split, which implies 14% downside from the current price. As I&#39;ve shared in past articles (1,2), the key assumption inmy model is that Tesla grows at a 25% CAGR over the next decade primarily due to growth in electric vehicle sales. While the upcoming Tesla stock split isn&#39;t material to my thesis, investors may have questions about how the split works, and I&#39;ll attempt to answer some of the common ones in this article.</p><p><b>Stock Split FAQs</b></p><p>I covered Tesla&#39;s stock split in my last article, but I&#39;ll recap a few of the key questions and answers about the split here. Those who read my previous article or are experienced with stock splits can skip to the next section.</p><p><b>How Do Stock Splits Impact Your Investment?</b></p><p>The total value of your investment isn&#39;t directly impacted by the stock split because a company&#39;s market cap is unchanged by stock splits. The decrease in price per share is offset by the increase in the number of shares you own.</p><p>For example, say Tesla is worth $900 before the split and you have one share. After the split, you&#39;ll have three shares, but each will be worth $300. Either way, you have $900. Of course, the value of Tesla stock may change as the market rises and falls from day to day, but that happens whether or not there&#39;s a split going on.</p><p>It&#39;s also worth noting that the price per share and price per options contract will be lower after the split, which will make non-fractional shares and options more accessible to small investors.</p><p><b>What Happens If You Buy Tesla Before The Split?</b></p><p>Buying Tesla stock before the split is not very different from buying it after the split or any other day. You&#39;d buy 3x fewer shares before the split as you would after the split in order to keep the total amount invested the same.</p><p><b>When Will Tesla Stock Split?</b></p><p>You will get two additional shares of Tesla stock for each share you already own on Wednesday, Aug. 24, after the market closes. Shares will trade at their post-split price starting on Thursday, Aug. 25.</p><p><b>How Many Times Has Tesla Stock Split?</b></p><p>This will be the second time that Tesla splits its stock. Tesla previously did a 5-for-1 stock split on Aug. 31, 2020. Shares have risen over 100% since then.</p><p><b>Is Tesla&#39;s Stock Split Good For Investors?</b></p><p>In other words, do stock splits impact performance? This is probably the most important question for most investors and also the most difficult to answer.</p><p>There&#39;s some evidence that companies that split their stock outperform in aggregate in the short term, perhaps in part because splitting allows some stocks to be included in indexes like the Dow and increases their accessibility to retail investors. However, looking at individual stocks, there are many cases where a stock declines around the time of its split. Thus, I wouldn&#39;t recommend betting on short-term price appreciation in a single stock because of its split.</p><p>However, splits certainly aren&#39;t bad news. They usually only happen after a stock has increased in value a lot, as Tesla stock has done over the past few years. Winners tend to keep winning, so betting on companies that already have done well can be a successful strategy.</p><p>Also, companies usually won&#39;t split their stock unless they believe that their share price will keep increasing. One reason is that there are minimum share price requirements to be listed on the NYSE and Nasdaq exchanges. That said, even at the post-split price of ~$300, Tesla is a long way from falling to the current $1 per share requirement.</p><p>Relative to more important considerations like earnings growth and valuation multiples, stock splits are essentially a neutral event for long-term investors. But in a vacuum, it&#39;s clear that stock splits are more positive than negative.</p><p><b>Q2 Earnings</b></p><p>Because the stock split doesn&#39;t impact Tesla&#39;s fundamentals, I won&#39;t adjust my target market cap for Tesla as a result of the split. However, I did update my price target for Tesla since my last article in June as a result of Tesla&#39;s Q2 earnings. I shared my updated $767 target with Tech Investing Edge members after Tesla reported.</p><p>I was disappointed by the earnings, mostly because I found slowing revenue growth more disappointing than a 27% EPS beat was impressive. After management constantly talked about Tesla&#39;s ability to maintain &gt;50% revenue growth over the coming quarters, growth fell to 42% in Q2. Considering that most Tesla models are heavily backordered, management correctly blamed the slowdown on production issues rather than a lack of demand. Even so, they admitted that 50% growth would be a more difficult target to attain going forward as they work to ramp up production.</p><p>I&#39;ve never believed Tesla&#39;s 50% growth target, and model them growing at a 25% CAGR over the coming decade. Nevertheless, I did expect them to stay above 50% for at least a few more quarters considering management&#39;s bullishness and my expectation for slower growth in the back half of the decade.</p><p>Despite the slowdown this quarter, I still think that my long-term 25% CAGR target is attainable, as even 42% growth is well above that level and management guided for a re-acceleration this quarter. Thus, despite being disappointed by the earnings, I raised my price target from $714 to $767 to account for Tesla&#39;s now-larger ttm revenue and EPS.</p><p><b>Conclusion</b></p><p>Stock splits tend to get a lot of media coverage, but for long-term investors they&#39;re not a big deal. Tesla has been able to split its stock multiple times because the company and Tesla stock have done very well, but that&#39;s not a guarantee of future performance.</p><p>If Tesla continues beating analysts&#39; expectations and growing quickly, then the company and its investors will likely continue to do well. However, production issues and competition could stop Tesla from reaching this goal, and the current valuation doesn&#39;t leave much room for error. Based on my own growth estimates and profitability model, I think that Tesla is slightly overvalued going into its stock split. Nevertheless, I view Tesla stock as a hold, since ~14% overvaluation isn&#39;t extreme.</p><p><i>This article was written by Kennan Mell. </i></p><p><i>This article is for reference only. You can take what is useful to you.</i></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Tesla's Stock Split Good For Investors?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Tesla's Stock Split Good For Investors?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-08-25 17:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4536846-tesla-stock-split-good-for-investors><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SummaryI answer some of the most common questions from investors about stock splits.Stock splits don't matter nearly as much as fundamentals, but they're certainly not bad for investors.I also recap ...</p>\n\n<a href=\"https://seekingalpha.com/article/4536846-tesla-stock-split-good-for-investors\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://seekingalpha.com/article/4536846-tesla-stock-split-good-for-investors","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2262018006","content_text":"SummaryI answer some of the most common questions from investors about stock splits.Stock splits don't matter nearly as much as fundamentals, but they're certainly not bad for investors.I also recap Tesla's recent Q2 earnings report.Ajax9/iStock Editorial via Getty ImagesThesisAfter Q2 earnings, I updated my price target for Tesla (NASDAQ:TSLA) stock to $765 pre-split, which implies 14% downside from the current price. As I've shared in past articles (1,2), the key assumption inmy model is that Tesla grows at a 25% CAGR over the next decade primarily due to growth in electric vehicle sales. While the upcoming Tesla stock split isn't material to my thesis, investors may have questions about how the split works, and I'll attempt to answer some of the common ones in this article.Stock Split FAQsI covered Tesla's stock split in my last article, but I'll recap a few of the key questions and answers about the split here. Those who read my previous article or are experienced with stock splits can skip to the next section.How Do Stock Splits Impact Your Investment?The total value of your investment isn't directly impacted by the stock split because a company's market cap is unchanged by stock splits. The decrease in price per share is offset by the increase in the number of shares you own.For example, say Tesla is worth $900 before the split and you have one share. After the split, you'll have three shares, but each will be worth $300. Either way, you have $900. Of course, the value of Tesla stock may change as the market rises and falls from day to day, but that happens whether or not there's a split going on.It's also worth noting that the price per share and price per options contract will be lower after the split, which will make non-fractional shares and options more accessible to small investors.What Happens If You Buy Tesla Before The Split?Buying Tesla stock before the split is not very different from buying it after the split or any other day. You'd buy 3x fewer shares before the split as you would after the split in order to keep the total amount invested the same.When Will Tesla Stock Split?You will get two additional shares of Tesla stock for each share you already own on Wednesday, Aug. 24, after the market closes. Shares will trade at their post-split price starting on Thursday, Aug. 25.How Many Times Has Tesla Stock Split?This will be the second time that Tesla splits its stock. Tesla previously did a 5-for-1 stock split on Aug. 31, 2020. Shares have risen over 100% since then.Is Tesla's Stock Split Good For Investors?In other words, do stock splits impact performance? This is probably the most important question for most investors and also the most difficult to answer.There's some evidence that companies that split their stock outperform in aggregate in the short term, perhaps in part because splitting allows some stocks to be included in indexes like the Dow and increases their accessibility to retail investors. However, looking at individual stocks, there are many cases where a stock declines around the time of its split. Thus, I wouldn't recommend betting on short-term price appreciation in a single stock because of its split.However, splits certainly aren't bad news. They usually only happen after a stock has increased in value a lot, as Tesla stock has done over the past few years. Winners tend to keep winning, so betting on companies that already have done well can be a successful strategy.Also, companies usually won't split their stock unless they believe that their share price will keep increasing. One reason is that there are minimum share price requirements to be listed on the NYSE and Nasdaq exchanges. That said, even at the post-split price of ~$300, Tesla is a long way from falling to the current $1 per share requirement.Relative to more important considerations like earnings growth and valuation multiples, stock splits are essentially a neutral event for long-term investors. But in a vacuum, it's clear that stock splits are more positive than negative.Q2 EarningsBecause the stock split doesn't impact Tesla's fundamentals, I won't adjust my target market cap for Tesla as a result of the split. However, I did update my price target for Tesla since my last article in June as a result of Tesla's Q2 earnings. I shared my updated $767 target with Tech Investing Edge members after Tesla reported.I was disappointed by the earnings, mostly because I found slowing revenue growth more disappointing than a 27% EPS beat was impressive. After management constantly talked about Tesla's ability to maintain >50% revenue growth over the coming quarters, growth fell to 42% in Q2. Considering that most Tesla models are heavily backordered, management correctly blamed the slowdown on production issues rather than a lack of demand. Even so, they admitted that 50% growth would be a more difficult target to attain going forward as they work to ramp up production.I've never believed Tesla's 50% growth target, and model them growing at a 25% CAGR over the coming decade. Nevertheless, I did expect them to stay above 50% for at least a few more quarters considering management's bullishness and my expectation for slower growth in the back half of the decade.Despite the slowdown this quarter, I still think that my long-term 25% CAGR target is attainable, as even 42% growth is well above that level and management guided for a re-acceleration this quarter. Thus, despite being disappointed by the earnings, I raised my price target from $714 to $767 to account for Tesla's now-larger ttm revenue and EPS.ConclusionStock splits tend to get a lot of media coverage, but for long-term investors they're not a big deal. Tesla has been able to split its stock multiple times because the company and Tesla stock have done very well, but that's not a guarantee of future performance.If Tesla continues beating analysts' expectations and growing quickly, then the company and its investors will likely continue to do well. However, production issues and competition could stop Tesla from reaching this goal, and the current valuation doesn't leave much room for error. Based on my own growth estimates and profitability model, I think that Tesla is slightly overvalued going into its stock split. Nevertheless, I view Tesla stock as a hold, since ~14% overvaluation isn't extreme.This article was written by Kennan Mell. This article is for reference only. You can take what is useful to you.","news_type":1},"isVote":1,"tweetType":1,"viewCount":480,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":266507427373096,"gmtCreate":1706100814428,"gmtModify":1706100819245,"author":{"id":"4094208649095680","authorId":"4094208649095680","name":"ECSY88","avatar":"https://community-static.tradeup.com/news/2ca1c7b2466a90f08306b9efc33770f1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"BABA.... soaring soon.","listText":"BABA.... soaring soon.","text":"BABA.... soaring soon.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/266507427373096","isVote":1,"tweetType":1,"viewCount":282,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9995181170,"gmtCreate":1661429341893,"gmtModify":1676536516656,"author":{"id":"4094208649095680","authorId":"4094208649095680","name":"ECSY88","avatar":"https://community-static.tradeup.com/news/2ca1c7b2466a90f08306b9efc33770f1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"No...","listText":"No...","text":"No...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9995181170","repostId":"2262018006","repostType":4,"repost":{"id":"2262018006","pubTimestamp":1661419523,"share":"https://www.laohu8.com/m/news/2262018006?lang=&edition=full","pubTime":"2022-08-25 17:25","market":"us","language":"en","title":"Is Tesla's Stock Split Good For Investors?","url":"https://stock-news.laohu8.com/highlight/detail?id=2262018006","media":"Seeking Alpha","summary":"This will be the second time that Tesla splits its stock. Tesla previously did a 5-for-1 stock split on Aug. 31, 2020. Shares have risen over 100% since then.Is Tesla's Stock Split Good For Investors?This is probably the most important question for most investors and also the most difficult to answer.There'ssome evidencethat companies that split their stock outperform in aggregate in the short term, perhaps in part because splitting allows some stocks to be included in indexes like the Dow and i","content":"<html><head></head><body><p><b>Summary</b></p><ul><li>I answer some of the most common questions from investors about stock splits.</li><li>Stock splits don&#39;t matter nearly as much as fundamentals, but they&#39;re certainly not bad for investors.</li><li>I also recap Tesla&#39;s recent Q2 earnings report.</li></ul><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ea05668b1422a0e51297e199e4d62ddc\" tg-width=\"1080\" tg-height=\"720\" referrerpolicy=\"no-referrer\"/><span>Ajax9/iStock Editorial via Getty Images</span></p><p><b>Thesis</b></p><p>After Q2 earnings, I updated my price target for Tesla (NASDAQ:TSLA) stock to $765 pre-split, which implies 14% downside from the current price. As I&#39;ve shared in past articles (1,2), the key assumption inmy model is that Tesla grows at a 25% CAGR over the next decade primarily due to growth in electric vehicle sales. While the upcoming Tesla stock split isn&#39;t material to my thesis, investors may have questions about how the split works, and I&#39;ll attempt to answer some of the common ones in this article.</p><p><b>Stock Split FAQs</b></p><p>I covered Tesla&#39;s stock split in my last article, but I&#39;ll recap a few of the key questions and answers about the split here. Those who read my previous article or are experienced with stock splits can skip to the next section.</p><p><b>How Do Stock Splits Impact Your Investment?</b></p><p>The total value of your investment isn&#39;t directly impacted by the stock split because a company&#39;s market cap is unchanged by stock splits. The decrease in price per share is offset by the increase in the number of shares you own.</p><p>For example, say Tesla is worth $900 before the split and you have one share. After the split, you&#39;ll have three shares, but each will be worth $300. Either way, you have $900. Of course, the value of Tesla stock may change as the market rises and falls from day to day, but that happens whether or not there&#39;s a split going on.</p><p>It&#39;s also worth noting that the price per share and price per options contract will be lower after the split, which will make non-fractional shares and options more accessible to small investors.</p><p><b>What Happens If You Buy Tesla Before The Split?</b></p><p>Buying Tesla stock before the split is not very different from buying it after the split or any other day. You&#39;d buy 3x fewer shares before the split as you would after the split in order to keep the total amount invested the same.</p><p><b>When Will Tesla Stock Split?</b></p><p>You will get two additional shares of Tesla stock for each share you already own on Wednesday, Aug. 24, after the market closes. Shares will trade at their post-split price starting on Thursday, Aug. 25.</p><p><b>How Many Times Has Tesla Stock Split?</b></p><p>This will be the second time that Tesla splits its stock. Tesla previously did a 5-for-1 stock split on Aug. 31, 2020. Shares have risen over 100% since then.</p><p><b>Is Tesla&#39;s Stock Split Good For Investors?</b></p><p>In other words, do stock splits impact performance? This is probably the most important question for most investors and also the most difficult to answer.</p><p>There&#39;s some evidence that companies that split their stock outperform in aggregate in the short term, perhaps in part because splitting allows some stocks to be included in indexes like the Dow and increases their accessibility to retail investors. However, looking at individual stocks, there are many cases where a stock declines around the time of its split. Thus, I wouldn&#39;t recommend betting on short-term price appreciation in a single stock because of its split.</p><p>However, splits certainly aren&#39;t bad news. They usually only happen after a stock has increased in value a lot, as Tesla stock has done over the past few years. Winners tend to keep winning, so betting on companies that already have done well can be a successful strategy.</p><p>Also, companies usually won&#39;t split their stock unless they believe that their share price will keep increasing. One reason is that there are minimum share price requirements to be listed on the NYSE and Nasdaq exchanges. That said, even at the post-split price of ~$300, Tesla is a long way from falling to the current $1 per share requirement.</p><p>Relative to more important considerations like earnings growth and valuation multiples, stock splits are essentially a neutral event for long-term investors. But in a vacuum, it&#39;s clear that stock splits are more positive than negative.</p><p><b>Q2 Earnings</b></p><p>Because the stock split doesn&#39;t impact Tesla&#39;s fundamentals, I won&#39;t adjust my target market cap for Tesla as a result of the split. However, I did update my price target for Tesla since my last article in June as a result of Tesla&#39;s Q2 earnings. I shared my updated $767 target with Tech Investing Edge members after Tesla reported.</p><p>I was disappointed by the earnings, mostly because I found slowing revenue growth more disappointing than a 27% EPS beat was impressive. After management constantly talked about Tesla&#39;s ability to maintain &gt;50% revenue growth over the coming quarters, growth fell to 42% in Q2. Considering that most Tesla models are heavily backordered, management correctly blamed the slowdown on production issues rather than a lack of demand. Even so, they admitted that 50% growth would be a more difficult target to attain going forward as they work to ramp up production.</p><p>I&#39;ve never believed Tesla&#39;s 50% growth target, and model them growing at a 25% CAGR over the coming decade. Nevertheless, I did expect them to stay above 50% for at least a few more quarters considering management&#39;s bullishness and my expectation for slower growth in the back half of the decade.</p><p>Despite the slowdown this quarter, I still think that my long-term 25% CAGR target is attainable, as even 42% growth is well above that level and management guided for a re-acceleration this quarter. Thus, despite being disappointed by the earnings, I raised my price target from $714 to $767 to account for Tesla&#39;s now-larger ttm revenue and EPS.</p><p><b>Conclusion</b></p><p>Stock splits tend to get a lot of media coverage, but for long-term investors they&#39;re not a big deal. Tesla has been able to split its stock multiple times because the company and Tesla stock have done very well, but that&#39;s not a guarantee of future performance.</p><p>If Tesla continues beating analysts&#39; expectations and growing quickly, then the company and its investors will likely continue to do well. However, production issues and competition could stop Tesla from reaching this goal, and the current valuation doesn&#39;t leave much room for error. Based on my own growth estimates and profitability model, I think that Tesla is slightly overvalued going into its stock split. Nevertheless, I view Tesla stock as a hold, since ~14% overvaluation isn&#39;t extreme.</p><p><i>This article was written by Kennan Mell. </i></p><p><i>This article is for reference only. You can take what is useful to you.</i></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is Tesla's Stock Split Good For Investors?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs Tesla's Stock Split Good For Investors?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-08-25 17:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4536846-tesla-stock-split-good-for-investors><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SummaryI answer some of the most common questions from investors about stock splits.Stock splits don't matter nearly as much as fundamentals, but they're certainly not bad for investors.I also recap ...</p>\n\n<a href=\"https://seekingalpha.com/article/4536846-tesla-stock-split-good-for-investors\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://seekingalpha.com/article/4536846-tesla-stock-split-good-for-investors","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2262018006","content_text":"SummaryI answer some of the most common questions from investors about stock splits.Stock splits don't matter nearly as much as fundamentals, but they're certainly not bad for investors.I also recap Tesla's recent Q2 earnings report.Ajax9/iStock Editorial via Getty ImagesThesisAfter Q2 earnings, I updated my price target for Tesla (NASDAQ:TSLA) stock to $765 pre-split, which implies 14% downside from the current price. As I've shared in past articles (1,2), the key assumption inmy model is that Tesla grows at a 25% CAGR over the next decade primarily due to growth in electric vehicle sales. While the upcoming Tesla stock split isn't material to my thesis, investors may have questions about how the split works, and I'll attempt to answer some of the common ones in this article.Stock Split FAQsI covered Tesla's stock split in my last article, but I'll recap a few of the key questions and answers about the split here. Those who read my previous article or are experienced with stock splits can skip to the next section.How Do Stock Splits Impact Your Investment?The total value of your investment isn't directly impacted by the stock split because a company's market cap is unchanged by stock splits. The decrease in price per share is offset by the increase in the number of shares you own.For example, say Tesla is worth $900 before the split and you have one share. After the split, you'll have three shares, but each will be worth $300. Either way, you have $900. Of course, the value of Tesla stock may change as the market rises and falls from day to day, but that happens whether or not there's a split going on.It's also worth noting that the price per share and price per options contract will be lower after the split, which will make non-fractional shares and options more accessible to small investors.What Happens If You Buy Tesla Before The Split?Buying Tesla stock before the split is not very different from buying it after the split or any other day. You'd buy 3x fewer shares before the split as you would after the split in order to keep the total amount invested the same.When Will Tesla Stock Split?You will get two additional shares of Tesla stock for each share you already own on Wednesday, Aug. 24, after the market closes. Shares will trade at their post-split price starting on Thursday, Aug. 25.How Many Times Has Tesla Stock Split?This will be the second time that Tesla splits its stock. Tesla previously did a 5-for-1 stock split on Aug. 31, 2020. Shares have risen over 100% since then.Is Tesla's Stock Split Good For Investors?In other words, do stock splits impact performance? This is probably the most important question for most investors and also the most difficult to answer.There's some evidence that companies that split their stock outperform in aggregate in the short term, perhaps in part because splitting allows some stocks to be included in indexes like the Dow and increases their accessibility to retail investors. However, looking at individual stocks, there are many cases where a stock declines around the time of its split. Thus, I wouldn't recommend betting on short-term price appreciation in a single stock because of its split.However, splits certainly aren't bad news. They usually only happen after a stock has increased in value a lot, as Tesla stock has done over the past few years. Winners tend to keep winning, so betting on companies that already have done well can be a successful strategy.Also, companies usually won't split their stock unless they believe that their share price will keep increasing. One reason is that there are minimum share price requirements to be listed on the NYSE and Nasdaq exchanges. That said, even at the post-split price of ~$300, Tesla is a long way from falling to the current $1 per share requirement.Relative to more important considerations like earnings growth and valuation multiples, stock splits are essentially a neutral event for long-term investors. But in a vacuum, it's clear that stock splits are more positive than negative.Q2 EarningsBecause the stock split doesn't impact Tesla's fundamentals, I won't adjust my target market cap for Tesla as a result of the split. However, I did update my price target for Tesla since my last article in June as a result of Tesla's Q2 earnings. I shared my updated $767 target with Tech Investing Edge members after Tesla reported.I was disappointed by the earnings, mostly because I found slowing revenue growth more disappointing than a 27% EPS beat was impressive. After management constantly talked about Tesla's ability to maintain >50% revenue growth over the coming quarters, growth fell to 42% in Q2. Considering that most Tesla models are heavily backordered, management correctly blamed the slowdown on production issues rather than a lack of demand. Even so, they admitted that 50% growth would be a more difficult target to attain going forward as they work to ramp up production.I've never believed Tesla's 50% growth target, and model them growing at a 25% CAGR over the coming decade. Nevertheless, I did expect them to stay above 50% for at least a few more quarters considering management's bullishness and my expectation for slower growth in the back half of the decade.Despite the slowdown this quarter, I still think that my long-term 25% CAGR target is attainable, as even 42% growth is well above that level and management guided for a re-acceleration this quarter. Thus, despite being disappointed by the earnings, I raised my price target from $714 to $767 to account for Tesla's now-larger ttm revenue and EPS.ConclusionStock splits tend to get a lot of media coverage, but for long-term investors they're not a big deal. Tesla has been able to split its stock multiple times because the company and Tesla stock have done very well, but that's not a guarantee of future performance.If Tesla continues beating analysts' expectations and growing quickly, then the company and its investors will likely continue to do well. However, production issues and competition could stop Tesla from reaching this goal, and the current valuation doesn't leave much room for error. Based on my own growth estimates and profitability model, I think that Tesla is slightly overvalued going into its stock split. Nevertheless, I view Tesla stock as a hold, since ~14% overvaluation isn't extreme.This article was written by Kennan Mell. This article is for reference only. You can take what is useful to you.","news_type":1},"isVote":1,"tweetType":1,"viewCount":480,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":266507225415960,"gmtCreate":1706100778427,"gmtModify":1706102391617,"author":{"id":"4094208649095680","authorId":"4094208649095680","name":"ECSY88","avatar":"https://community-static.tradeup.com/news/2ca1c7b2466a90f08306b9efc33770f1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/266507225415960","repostId":"265790492557464","repostType":1,"repost":{"id":265790492557464,"gmtCreate":1705910690889,"gmtModify":1705925769143,"author":{"id":"4089501973615070","authorId":"4089501973615070","name":"Optionspuppy","avatar":"https://static.tigerbbs.com/caf34258aff8afe478620b82647f1199","crmLevel":6,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"title":"Earnings for 4th quarter is on a positive note look at the futures ","htmlText":"** Fortune-Telling: Earnings Edition 🔮💸** **Point 1: The Trumpian Gaze into the Future** 👀🔮 I've got a tremendous talent, folks – looking at futures earnings, and let me tell you, they're positive for many, many days before the market opens. It's like predicting my next great business move – you just gotta have that instinct. **Point 2: Strong Earnings, Trump-Style** 📈💪 So, based on my tremendous foresight, I'm predicting strong earnings for most of the Nasdaq and S&amp;P stocks. It's like a winning streak at one of my luxurious golf courses – you can't lose. **Point 3: The Big Guns: Google, Amazon, Apple, Microsoft** 🚀💰 Now, let's talk about the big players – Google, Amazon, Apple, and Microsoft. These guys are sitting on a mountain of cash, and let me tell you, that's a big, beautiful","listText":"** Fortune-Telling: Earnings Edition 🔮💸** **Point 1: The Trumpian Gaze into the Future** 👀🔮 I've got a tremendous talent, folks – looking at futures earnings, and let me tell you, they're positive for many, many days before the market opens. It's like predicting my next great business move – you just gotta have that instinct. **Point 2: Strong Earnings, Trump-Style** 📈💪 So, based on my tremendous foresight, I'm predicting strong earnings for most of the Nasdaq and S&amp;P stocks. It's like a winning streak at one of my luxurious golf courses – you can't lose. **Point 3: The Big Guns: Google, Amazon, Apple, Microsoft** 🚀💰 Now, let's talk about the big players – Google, Amazon, Apple, and Microsoft. These guys are sitting on a mountain of cash, and let me tell you, that's a big, beautiful","text":"** Fortune-Telling: Earnings Edition 🔮💸** **Point 1: The Trumpian Gaze into the Future** 👀🔮 I've got a tremendous talent, folks – looking at futures earnings, and let me tell you, they're positive for many, many days before the market opens. It's like predicting my next great business move – you just gotta have that instinct. **Point 2: Strong Earnings, Trump-Style** 📈💪 So, based on my tremendous foresight, I'm predicting strong earnings for most of the Nasdaq and S&P stocks. It's like a winning streak at one of my luxurious golf courses – you can't lose. **Point 3: The Big Guns: Google, Amazon, Apple, Microsoft** 🚀💰 Now, let's talk about the big players – Google, Amazon, Apple, and Microsoft. These guys are sitting on a mountain of cash, and let me tell you, that's a big, beautiful","images":[{"img":"https://community-static.tradeup.com/news/a370ee8ccfcb2eb9aa93329dffac13df","width":"1242","height":"1145"},{"img":"https://community-static.tradeup.com/news/425fb214f5056404c676b9876dc8cee8","width":"1536","height":"2048"},{"img":"https://community-static.tradeup.com/news/3105b1b305cb79675afd1e2a09599626","width":"1242","height":"2004"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/265790492557464","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":4,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":340,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9922540339,"gmtCreate":1671808379222,"gmtModify":1676538597162,"author":{"id":"4094208649095680","authorId":"4094208649095680","name":"ECSY88","avatar":"https://community-static.tradeup.com/news/2ca1c7b2466a90f08306b9efc33770f1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"[Smile]&nbsp;","listText":"[Smile]&nbsp;","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9922540339","repostId":"9922552955","repostType":1,"isVote":1,"tweetType":1,"viewCount":368,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9939226018,"gmtCreate":1662120753735,"gmtModify":1676537002269,"author":{"id":"4094208649095680","authorId":"4094208649095680","name":"ECSY88","avatar":"https://community-static.tradeup.com/news/2ca1c7b2466a90f08306b9efc33770f1","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"[Smile]&nbsp;","listText":"[Smile]&nbsp;","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9939226018","repostId":"2264296558","repostType":4,"repost":{"id":"2264296558","pubTimestamp":1662107204,"share":"https://www.laohu8.com/m/news/2264296558?lang=&edition=full","pubTime":"2022-09-02 16:26","market":"us","language":"en","title":"3 Dividend Stocks to Buy in September for Passive Income Generation","url":"https://stock-news.laohu8.com/highlight/detail?id=2264296558","media":"Motley Fool","summary":"Buying these stocks now could lead to dividend payments that grow for the rest of your life.","content":"<html><head></head><body><p>Do you like getting paid to do practically nothing? I thought so.</p><p>Lots of savvy investors know that they can generate heaps of passive income with dividend-paying stocks. These three businesses are more than just reliable dividend payers; they&#39;re known for raising their dividend payouts year after year. Here&#39;s how they could provide ever-increasing dividend payments to your brokerage account.</p><h2>1. <a href=\"https://laohu8.com/S/ABT\">Abbott Laboratories </a></h2><p>This healthcare conglomerate&#39;s COVID-19 tests made it a stock market darling in 2021. Shares of <a href=\"https://laohu8.com/S/ABT\">Abbott Laboratories </a> have tumbled around 27% since the beginning of 2022 in response to subsiding demand for COVID tests. Now the stock offers a tempting 1.8% dividend yield that could rise significantly in the years ahead.</p><p>In the second quarter, COVID-19 testing-related sales fell to $2.3 billion from $3.3 billion during the first quarter of 2022. Luckily for long-term investors, the company could report significant earnings growth even if COVID-19 sales fall off a cliff.</p><p>Declining COVID-19 testing revenue isn&#39;t a major issue for this diversified conglomerate because its diabetes-care segment is about to rocket higher. In May, the FDA granted clearance to Abbott&#39;s FreeStyle Libre 3 system. This device is only the size of a couple of pennies stacked together, but once a patient sticks it on her or his arm, it monitors blood sugar levels constantly for two weeks.</p><p>Constant monitoring leads to fewer interventions in expensive hospitals, so insurers and government payers are eager to reimburse patients for the devices. With glucose monitoring sales about to explode higher, Abbott could approve some big dividend raises in the foreseeable future.</p><h2>2. <a href=\"https://laohu8.com/S/CVS\">CVS Health </a></h2><p>Shares of <a href=\"https://laohu8.com/S/CVS\">CVS Health </a> surged late last year when the company announced that it would begin raising its dividend payout again. Since then, the stock has been in a holding pattern.</p><p>At recent prices, shares of CVS Health offer a 2.2% yield that could grow significantly in the years ahead. In addition to thousands of retail pharmacies, this conglomerate owns a pharmacy benefits management business that boasts more than 110 million plan members.</p><p>Integrating a pharmacy benefits management business is one advantage its peers in the retail pharmacy space can&#39;t match, and it isn&#39;t the company&#39;s only big advantage. CVS Health previously paused raising its dividend payout to pay off its acquisition of Aetna, a health insurer that currently collects premiums from an estimated 35 million members.</p><p>CVS Health&#39;s unique combination of related businesses allowed the company to raise its dividend payout by 10% this year. Without any competitors combining a large retail footprint with a health benefits management business, the latest big payout bump could be the first of many in the years ahead.</p><h2>3. <a href=\"https://laohu8.com/S/ABBV\">AbbVie </a></h2><p><a href=\"https://laohu8.com/S/ABBV\">AbbVie </a> was once the pharmaceutical segment of Abbott Laboratories. Shares of AbbVie offer an above-average yield of 4.2% that could climb even higher.</p><p>Since the drugmaker spun off in 2013, its dividend has risen an astonishing 253% on the back of its lead drug, Humira. Second-quarter sales of Humira rose 9.6% year over year to a stunning $4.7 billion in the U.S. Unfortunately, international Humira revenue fell 13.8% to $699 million.</p><p>AbbVie offers an above-average dividend now because U.S. Humira sales will soon go the same way as international sales. An interchangeable biosimilar version of the anti-inflammatory blockbuster became available in the U.S. this July.</p><p>AbbVie investors can expect their dividend payouts to continue rising in the face of Humira competition because the company has new blockbuster drugs to pick up the slack. Second-quarter sales of Rinvoq, a new arthritis drug, and Skyrizi, a new psoriasis drug, soared 75% year over year to a combined $1.84 billion. With new blockbusters to offset Humira losses, AbbVie shareholders could see more big payout bumps in the years ahead.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Dividend Stocks to Buy in September for Passive Income Generation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Dividend Stocks to Buy in September for Passive Income Generation\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-09-02 16:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/09/01/3-dividend-stocks-to-buy-in-september-for-passive/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Do you like getting paid to do practically nothing? I thought so.Lots of savvy investors know that they can generate heaps of passive income with dividend-paying stocks. These three businesses are ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/09/01/3-dividend-stocks-to-buy-in-september-for-passive/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4581":"高盛持仓","CVS":"西维斯健康","BK4139":"生物科技","ABT":"雅培","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4568":"美国抗疫概念","BK4504":"桥水持仓","BK4566":"资本集团","BK4535":"淡马锡持仓","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓","ABBV":"艾伯维公司"},"source_url":"https://www.fool.com/investing/2022/09/01/3-dividend-stocks-to-buy-in-september-for-passive/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2264296558","content_text":"Do you like getting paid to do practically nothing? I thought so.Lots of savvy investors know that they can generate heaps of passive income with dividend-paying stocks. These three businesses are more than just reliable dividend payers; they're known for raising their dividend payouts year after year. Here's how they could provide ever-increasing dividend payments to your brokerage account.1. Abbott Laboratories This healthcare conglomerate's COVID-19 tests made it a stock market darling in 2021. Shares of Abbott Laboratories  have tumbled around 27% since the beginning of 2022 in response to subsiding demand for COVID tests. Now the stock offers a tempting 1.8% dividend yield that could rise significantly in the years ahead.In the second quarter, COVID-19 testing-related sales fell to $2.3 billion from $3.3 billion during the first quarter of 2022. Luckily for long-term investors, the company could report significant earnings growth even if COVID-19 sales fall off a cliff.Declining COVID-19 testing revenue isn't a major issue for this diversified conglomerate because its diabetes-care segment is about to rocket higher. In May, the FDA granted clearance to Abbott's FreeStyle Libre 3 system. This device is only the size of a couple of pennies stacked together, but once a patient sticks it on her or his arm, it monitors blood sugar levels constantly for two weeks.Constant monitoring leads to fewer interventions in expensive hospitals, so insurers and government payers are eager to reimburse patients for the devices. With glucose monitoring sales about to explode higher, Abbott could approve some big dividend raises in the foreseeable future.2. CVS Health Shares of CVS Health  surged late last year when the company announced that it would begin raising its dividend payout again. Since then, the stock has been in a holding pattern.At recent prices, shares of CVS Health offer a 2.2% yield that could grow significantly in the years ahead. In addition to thousands of retail pharmacies, this conglomerate owns a pharmacy benefits management business that boasts more than 110 million plan members.Integrating a pharmacy benefits management business is one advantage its peers in the retail pharmacy space can't match, and it isn't the company's only big advantage. CVS Health previously paused raising its dividend payout to pay off its acquisition of Aetna, a health insurer that currently collects premiums from an estimated 35 million members.CVS Health's unique combination of related businesses allowed the company to raise its dividend payout by 10% this year. Without any competitors combining a large retail footprint with a health benefits management business, the latest big payout bump could be the first of many in the years ahead.3. AbbVie AbbVie  was once the pharmaceutical segment of Abbott Laboratories. Shares of AbbVie offer an above-average yield of 4.2% that could climb even higher.Since the drugmaker spun off in 2013, its dividend has risen an astonishing 253% on the back of its lead drug, Humira. Second-quarter sales of Humira rose 9.6% year over year to a stunning $4.7 billion in the U.S. Unfortunately, international Humira revenue fell 13.8% to $699 million.AbbVie offers an above-average dividend now because U.S. Humira sales will soon go the same way as international sales. An interchangeable biosimilar version of the anti-inflammatory blockbuster became available in the U.S. this July.AbbVie investors can expect their dividend payouts to continue rising in the face of Humira competition because the company has new blockbuster drugs to pick up the slack. Second-quarter sales of Rinvoq, a new arthritis drug, and Skyrizi, a new psoriasis drug, soared 75% year over year to a combined $1.84 billion. With new blockbusters to offset Humira losses, AbbVie shareholders could see more big payout bumps in the years ahead.","news_type":1},"isVote":1,"tweetType":1,"viewCount":189,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}